Evolution of the Average Target: Hubbell Incorporated

Evolution of the Target Price: Hubbell Incorporated

Changes in Analyst Recommendations: Hubbell Incorporated

d27d50.5TLhLoSQKAEwE7olYvkEbHoZ7bkZZDk37gDRL8X-51U.3F7TSLTJRltKccBwMLE3LVdeptFWNEplv0GAX6edrDqoSJNo6v8ce2ZU1Q~2882447e47de4285019ba0a2ca6050dd
Morgan Stanley Trims Price Target on Hubbell to $435 From $445, Keeps Equalweight Rating Feb. 05 MT
Deutsche Bank Adjusts Hubbell Price Target to $458 From $475, Maintains Hold Rating Feb. 05 MT
Deutsche Bank Adjusts Hubbell Price Target to $475 From $473 Jan. 13 MT
Barclays Adjusts Price Target on Hubbell to $475 From $402 Dec. 05 MT
Deutsche Bank Downgrades Hubbell to Hold From Buy, Adjusts Price Target to $473 From $493 Nov. 26 MT
Analyst recommendations: Chevron, Morgan Stanley, Goldman Sachs, Affirm Holdings, Moderna... Nov. 26Our Logo
Vertical Adjusts Price Target on Hubbell to $500 From $460 Nov. 11 MT
Bernstein Initiates Hubbell at Outperform With $535 Price Target Nov. 05 MT
Seaport Adjusts Price Target on Hubbell to $485 From $420 24-10-30 MT
Wells Fargo Adjusts Price Target on Hubbell to $455 From $445 24-10-30 MT
Barclays Adjusts Price Target on Hubbell to $402 From $400 24-10-30 MT
Morgan Stanley Adjusts Price Target on Hubbell to $445 From $407 24-10-30 MT
Deutsche Bank Adjusts Price Target on Hubbell to $493 From $482 24-10-30 MT
Stephens Adjusts Hubbell's Price Target to $500 From $450, Keeps Overweight Rating 24-10-29 MT
Stephens Adjusts Price Target on Hubbell to $450 From $500 24-10-29 MT
Deutsche Bank Adjusts Price Target on Hubbell to $482 From $438 24-10-22 MT
Mizuho Securities Adjusts Price Target on Hubbell to $490 From $450 24-10-17 MT
Stephens Adjusts Price Target on Hubbell to $500 From $450, Maintains Overweight Rating 24-10-16 MT
JPMorgan Downgrades Hubbell to Neutral From Overweight, Adjusts Price Target to $454 From $385 24-10-10 MT
Analyst recommendations: CVS Health, Hubbell Inc, Lucid Group, Medtronic, PayPal... 24-10-10Our Logo
Wells Fargo Adjusts Price Target on Hubbell to $445 From $400 24-10-07 MT
Barclays Adjusts Price Target on Hubbell to $400 From $368, Maintains Equalweight Rating 24-10-02 MT
Deutsche Bank Adjusts Price Target on Hubbell to $438 From $441 24-10-02 MT
Vertical Research Adjusts Price Target on Hubbell to $460 From $415 24-09-26 MT
Deutsche Bank Upgrades Hubbell to Buy From Hold, Adjusts Price Target to $441 From $431 24-09-06 MT
More recommendations

Add to a list
Consensus 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+13.32%
+7.02%
+11.98%
+18.69%
+12.96%
+20.38%
+0.8%
+10.5%
+12.51%
+21.44%
Average +12.96%
Weighted average by Cap. +12.37%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
394.99USD
Average target price
453.36USD
Spread / Average Target
+14.78%
High Price Target
507.00USD
Spread / Highest target
+28.36%
Low Price Target
383.00USD
Spread / Lowest Target
-3.04%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Deutsche Bank Securities
Morgan Stanley
Barclays
Vertical Research
Bernstein
Wells Fargo Securities
Seaport Global Securities
Stephens Inc.
Mizuho Securities
JPMorgan Chase
UBS
TD Cowen
Wolfe Research
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. HUBB Stock
  4. Consensus Hubbell Incorporated